EZH2 and mantle cell lymphoma: In contrast, no synergistic effect was observed in wild-type EZH2 DLBCL cell lines (OCI-LY-19, SU-DHL4, and Toledo) (Figure 1J,K and Figure S1E–H) and other lymphoma types, such as mantle cell lymphoma (JeKo-1, Rec-1, Mino, and Z138) and Burkitt’s lymphoma (NC-37) (Figure S1I–M).